Skin codelivery of contact sensitizers and neurokinin-1 receptor antagonists integrated in microneedle arrays suppresses allergic contact dermatitis.

MLA

Bandyopadhyay, Mohna, et al. “Skin Codelivery of Contact Sensitizers and Neurokinin-1 Receptor Antagonists Integrated in Microneedle Arrays Suppresses Allergic Contact Dermatitis.” The Journal of Allergy and Clinical Immunology, vol. 150, no. 1, July 2022, pp. 114–30. EBSCOhost, https://doi.org/10.1016/j.jaci.2021.12.794.

APA

Bandyopadhyay, M., Morelli, A. E., Balmert, S. C., Ward, N. L., Erdos, G., Sumpter, T. L., Korkmaz, E., Kaplan, D. H., Oberbarnscheidt, M. H., Tkacheva, O., Shufesky, W. J., Falo, L. D., Jr, & Larregina, A. T. (2022). Skin codelivery of contact sensitizers and neurokinin-1 receptor antagonists integrated in microneedle arrays suppresses allergic contact dermatitis. The Journal of Allergy and Clinical Immunology, 150(1), 114–130. https://doi.org/10.1016/j.jaci.2021.12.794

Chicago

Bandyopadhyay, Mohna, Adrian E Morelli, Stephen C Balmert, Nicole L Ward, Geza Erdos, Tina L Sumpter, Emrullah Korkmaz, et al. 2022. “Skin Codelivery of Contact Sensitizers and Neurokinin-1 Receptor Antagonists Integrated in Microneedle Arrays Suppresses Allergic Contact Dermatitis.” The Journal of Allergy and Clinical Immunology 150 (1): 114–30. doi:10.1016/j.jaci.2021.12.794.